CEL-SCI Corporation (CVM)

ASE – Real Time Price. Currency in USD

1.19

-0.22 (-15.60%)

At close: May 12, 2026, 4:00 PM EDT

1.14

-0.05 (-4.20%)

Pre-market: May 13, 2026, 4:59 AM EDT

12.05.2026

CEL-SCI Corporation Announces Pricing of Public Offering

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation Announces Pricing of Public Offering.

11.05.2026

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia.

18.02.2026

CEL-SCI Reports Fiscal First Quarter 2026 Results

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reported financial results for three months ended December 31, 2025, as well as key recent clinical and corporate developments.

29.12.2025

CEL-SCI Reports Fiscal 2025 Results

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation reports financial results for the fiscal year ended September 30, 2025, as well as key clinical and corporate developments.

20.10.2025

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

Vienna, Virginia--(Newsfile Corp. - October 20, 2025) - CEL-SCI Corporation (NYSE American: CVM), a clinical stage cancer immunotherapy company, previously announced that Geert Kersten, Chief Executive Officer, is scheduled to present at the LD Micro "Main Event" Investor Conference on October 21, 2025. You can register to watch the virtual presentation at 9:30 a.m.

14.07.2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of $5.7 million offering priced at-the-market under NYSE American rules.

Videos

No Data

There is no data to display

Press releases

12.05.2026

CEL-SCI Corporation Announces Pricing of Public Offering

VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI Corporation Announces Pricing of Public Offering.

CEL-SCI Corporation (CVM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CEL-SCI Corporation (CVM)

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

Videos

No Data

Press releases

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

Videos

No Data

Press releases

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results

Search stocks

CEL-SCI Corporation (CVM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CEL-SCI Corporation (CVM)

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

Videos

No Data

Press releases

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results

CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025

CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

Videos

No Data

Press releases

CEL-SCI Corporation Announces Pricing of Public Offering

CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia

CEL-SCI Reports Fiscal First Quarter 2026 Results

CEL-SCI Reports Fiscal 2025 Results